CdLS Gene Discovered

Courtesy of Trident Photographic ServicesUK and US teams independently pinpointed a gene for Cornelia de Lange syndrome (CdLS), ending a 15-year search.12 Tests for the disorder may be forthcoming. CdLS occurs in 1 in 30,000–40,000 births, causing debilitating growth problems and deformities as well as behavioral difficulties. Misdiagnoses can result in patients succumbing to potentially fatal problems such as twisted bowel.Independently, Tom Strachan1 at University of Newcastle, UK, and I

Written byDavid Bradley
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Courtesy of Trident Photographic Services

UK and US teams independently pinpointed a gene for Cornelia de Lange syndrome (CdLS), ending a 15-year search.12 Tests for the disorder may be forthcoming. CdLS occurs in 1 in 30,000–40,000 births, causing debilitating growth problems and deformities as well as behavioral difficulties. Misdiagnoses can result in patients succumbing to potentially fatal problems such as twisted bowel.

Independently, Tom Strachan1 at University of Newcastle, UK, and Ian Krantz2 at the Children's Hospital of Philadelphia and their colleagues linked the disease to sporadic mutations in NIBPL on chromosome 5. This regulatory gene affects organ development. "Clinical geneticists have been waiting for this discovery for years," says Andreas Zankl of the Division of Molecular Pediatrics at the Centre Hospitalier Universitaire Vaudois in Lausanne, Switzerland. Strachan's colleague Emma Tonkin (pictured above) explains, "Some children who have only mild learning difficulties may go undiagnosed." A reliable diagnostic test would ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies